EN
			
			
			In view of the data indicating that insulin   can modify penetration of some drugs across cell membranes and tissue   barriers, particularly the blood-brain barrier, the aim of the present   study was to evaluate the effect of insulin on both the anticonvulsant   activity and the brain concentration of carbamazepine in mice suffering   from seizures induced by maximal electroshock. The antiepileptic drug   was administered per os in single doses either alone or in combination   with insulin given as single intraperitoneal injections. To assess   the anticonvulsant activity of carbamazepine the ED50 values   were calculated. The results indicate that insulin given in doses   up to 2 units/kg did not affect the convulsive threshold, whereas   insulin applied at 2 units/kg led to a significant reduction in the   anticonvulsant activity of carbamazepine, as judged by an increase   in the ED50 value from 16.2 to 41.3 mg/kg. This effect was   accompanied by the marked reduction in both the brain and blood concentrations   of the drug. It is likely, therefore, that the inhibitory activity   of insulin on the anticonvulsive function of carbamazepine is related   not only to the effect of the former on the blood-brain transport   of the latter, but also to insulin-induced modulation of the serum   concentration of the drug.